Whitehawk Therapeutics, Inc. (WHWK) stock news · rev $7.1M
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
This WHWK news page leads with what Whitehawk Therapeutics, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for WHWK yet. We will not pad this page with generic market recap.
Latest reported WHWK revenue for 2025-12-31 was $7.1M. Net income was -$20.6M. Revenue was down 72.5% from 2024-12-31 to 2025-12-31. WHWK currently screens at market cap $202.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the WHWK stock page; for the tape open the quote page.
WHWK stock news FAQ
What are WHWK's latest revenue and net income?
Latest cached Whitehawk Therapeutics, Inc. (WHWK) revenue for Dec 31, 2025 was $7.1M. Net income was -$20.6M. Statements: https://lician.com/financials/whwk
How did WHWK revenue change from the prior cached period?
Cached Whitehawk Therapeutics, Inc. (WHWK) revenue was down 72.5% from $26.0M (Dec 31, 2024) to $7.1M (Dec 31, 2025). Statements: https://lician.com/financials/whwk
What is WHWK's market cap?
Whitehawk Therapeutics, Inc. (WHWK) market cap is $202.8M on the latest cached fundamentals snapshot.
What kind of company is WHWK?
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Where is WHWK stock news listed?
Cached stock news for Whitehawk Therapeutics, Inc. (WHWK) is listed at https://lician.com/news/whwk. Filings: https://lician.com/sec/whwk
Not investment advice.